243 related articles for article (PubMed ID: 28274953)
1. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma.
Olsson DS; Hammarstrand C; Bryngelsson IL; Nilsson AG; Andersson E; Johannsson G; Ragnarsson O
Endocr Relat Cancer; 2017 May; 24(5):227-235. PubMed ID: 28274953
[TBL] [Abstract][Full Text] [Related]
2. Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Eur J Endocrinol; 2016 Jul; 175(1):55-61. PubMed ID: 27147638
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
4. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
6. Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.
Olsson DS; Nilsson AG; Bryngelsson IL; Trimpou P; Johannsson G; Andersson E
J Clin Endocrinol Metab; 2015 Jul; 100(7):2651-8. PubMed ID: 25946030
[TBL] [Abstract][Full Text] [Related]
7. Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Pituitary; 2017 Apr; 20(2):218-224. PubMed ID: 27743172
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
9. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
10. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
11. Incidence of a second tumor in hypopituitary patients operated for pituitary tumors.
Erfurth EM; Bülow B; Mikoczy Z; Hagmar L
J Clin Endocrinol Metab; 2001 Feb; 86(2):659-62. PubMed ID: 11158027
[TBL] [Abstract][Full Text] [Related]
12. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
[TBL] [Abstract][Full Text] [Related]
13. Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study.
Oh JS; Kim HJ; Hann HJ; Kang TU; Kim DS; Kang MJ; Lee JY; Shim JJ; Lee MR; Ahn HS
Pituitary; 2021 Feb; 24(1):38-47. PubMed ID: 32949324
[TBL] [Abstract][Full Text] [Related]
14. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.
Popovic V; Damjanovic S; Micic D; Nesovic M; Djurovic M; Petakov M; Obradovic S; Zoric S; Simic M; Penezic Z; Marinkovic J
Clin Endocrinol (Oxf); 1998 Oct; 49(4):441-5. PubMed ID: 9876340
[TBL] [Abstract][Full Text] [Related]
15. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
[TBL] [Abstract][Full Text] [Related]
16. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cancer among patients with atopic dermatitis.
Hagströmer L; Ye W; Nyrén O; Emtestam L
Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
[TBL] [Abstract][Full Text] [Related]
18. Incidence and familial risks in pituitary adenoma and associated tumors.
Hemminki K; Försti A; Ji J
Endocr Relat Cancer; 2007 Mar; 14(1):103-9. PubMed ID: 17395979
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine.
Zar N; Garmo H; Holmberg L; Hellman P
Eur J Cancer; 2008 Mar; 44(5):718-25. PubMed ID: 18207733
[TBL] [Abstract][Full Text] [Related]
20. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]